Modifications in lipoprotein surface charge alter cyclosporine A association with low-density lipoproteins

Pharm Res. 2003 Jan;20(1):126-9. doi: 10.1023/a:1022215228799.

Abstract

Purpose: The purpose of this study was to examine the influence of lipoprotein surface charge on the plasma distribution of cyclosporine A (CSA).

Methods: Phosphatidylinositol (PI; 40 micromol) was administered intravenously to rabbits. Blood was removed 10 min after injection and plasma was retrieved. Radiolabeled CSA ([3H] CSA) at a concentration of 1000 ng/mL was incubated for 60 min at 37 degrees C in control and PI-treated rabbit plasma. After incubation, plasma was separated into its lipoprotein and lipoprotein-deficient plasma (LPDP) fractions by density gradient ultracentrifugation, and the percentage of [3H]CSA recovered in each fraction was determined by radioactivity. To determine lipoprotein surface charge within control and PI-treated plasma, the zeta potential of each lipoprotein fraction was measured. The effect of PI on lipoprotein surface charge was further confirmed by gel electrophoresis.

Results: PI treatment caused low-density lipoprotein (LDL) fraction to migrate further on the agarose gel, indicative of an increased negative surface charge. Zeta potential analysis further showed that LDL particles had a surface potential of -11.4 +/- 1.9 mV and -17.4 +/- 3 mV in control and PI-treated groups, respectively. A greater percentage of [3H]CSA was recovered within the LDL (16.4 +/-1.1% vs. 7.7 +/- 2.1%; n = 3; p < 0.05) fraction after incubation in PI treated than in control plasma, respectively.

Conclusion: These findings suggest that modifications in lipoprotein surface charge alter CSA distribution within the LDL plasma fraction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclosporine / chemistry*
  • Cyclosporine / pharmacokinetics*
  • Humans
  • Lipoproteins, LDL / metabolism*
  • Particle Size
  • Rabbits
  • Surface Properties

Substances

  • Lipoproteins, LDL
  • Cyclosporine